Teva Announces Final Approval of Ribavirin Tablets (Hep C Chronic Fatigue)

Teva Announces Final Approval of Ribavirin Tablets
Pharma Live - peginterferon alfa-2a for treatment of adults with chronic hepatitis C virus who have compensated liver disease and have

Decreased Prevalence of Steatosis after Treatment for Chronic Hepatitis C in HIV-HCV Coinfected Subjects
HIV and Hepatitis.com - By Marina Nunez, MD Factors associated with hepatic steatosis in HIV/HCV-coinfected patients concerning its influence on response to treatment are not clear.